Indoco Remedies' testing facility completes US FDA PAI

The U.S. Food and Drug Administration (U.S. FDA) completed Pre-Approval Inspection (PAI) at the Company's testing facility in Chhatrapati Sambaji Nagar (Aurangabad). The inspection was carried out from April 08, 2026 to April 10, 2026, and concluded with zero form 483 observations.

Panacea Biotec receives LoA from CMSS

Panacea Biotec Limited has received a Letter of Award dated April 10, 2026 (LOA) from Central Medical Services Society, Ministry of Health and Family Welfare, Government of India (CMSS).

As per the LOA, the company will supply Diphtheria and Tetanus Vaccine (Absorbed) for Adults and Adolescents IP (Td Vaccine) in several tranches to CMSS starting from September / October 2026 till November / December 2028 for the value aggregating to Rs. 20.79 crore.